Latest News and Press Releases

Borregaard ASA has issued a commercial paper ISIN NO0013708651 of NOK 100,000,000. Start date: 12 December, 2025Maturity: 12 February, 2026Coupon: 4,43 %Organised by: DNB Carnegie Sarpsborg, 10...

Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while...

15 October 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Presentation of Q3 2025 results Borregaard will report third quarter 2025 results on Wednesday 22 October 2025 at 07:00 CEST. A stock...

Borregaard ASA has issued a commercial paper ISIN NO0013683730 of NOK 100,000,000. Start date: 14 October, 2025Maturity: 12 December, 2025Coupon: 4,20 %Organised by: DNB Markets Sarpsborg, 10...

Borregaard, together with the shareholders Must Invest and Hatteland Group, will act as guarantors for a NOK 200 million convertible loan to Alginor. The loan may be converted to new shares by the...

The Norwegian Research Council (NFR) has awarded NOK 15 million to support Borregaard’s innovation initiative, Biomer. The project aims to develop bio-based alternatives to polycarboxylates –...

Borregaard has experienced an unforeseen outage at a facility at the Sarpsborg site, which supplies a key chemical used in the production of speciality cellulose. During the period of the outage,...

Borregaard's Board of Directors has issued 30,000 share options in relation to the CEO appointment. Reference is made to stock exchange release on 23 May 2025. The options will expire after five...

Tom Erik Foss-Jacobsen assumed his position as Borregaard’s new CEO on 1 August (see notice to Oslo Stock Exchange 23 May 2025). “Borregaard is well positioned with six production units, three...

Borregaard’s operating revenues increased to NOK 2,045 million (NOK 1,949 million)2 in the 2nd quarter of 2025. EBITDA1 reached NOK 522 million (NOK 510 million). The result in BioSolutions and...